Susan Hasty, Publisher
Table of Contents . . . January 27th, 1997Non-Subscriber - Summaries Only
Corrective Gene Therapy (CGD) - Gene Transfer Corrects Defect in Host Defense against Infection
Antisense Technology - Anticancer Drug Demonstrates Antitumor Activity In Vivo
Antisense Technology - Compound Aimed at Reducing Serum Cholesterol Levels
Breast Cancer - Random Homozygous Knockout Method Discovers Cancer Gene
Cancer Gene Therapy - Transfection of Chronic Lymphocytic Leukemia B Cells Possible
Industry News (Joint Venture) - Collaboration Established for Combinatorial Drug Discovery
Industry News (Joint Venture) - Collaboration Extension Agreement for Viral Gene Regulation Announced
Industry News (Joint Venture) - DNA Sequenced by Time-of-Flight Mass Spectrometry
Industry News (Joint Venture) - Gene Discovery Collaboration Announced for Prostate Cancer
Industry News (Joint Venture) - Merger Establishes Gene Therapy Company
Suicide Gene Therapy - Bystander Effect Inhibited by the Drug Verapamil
Vector Development - Modified Herpes Vector Efficiently Transfects Hematopoietic Cells
Gene Transfer Efficiencies - "In Vivo Gene Transfer to Hepatocellular Carcinoma (HCC) in Experimental Animal Models by Adenoviral Vector."
HIV Vaccines - "HIV Vaccines - Towards Phase III."
In Utero Gene Therapy - "In Utero Transplacental Adenoviral Gene Transfer to Murine Fetal Heart."
Pathogenesis (Adenovirus Vector) - "In Vivo Gene Transfer Using Replication Deficient Adenovirus Vector Alters Vasomotricity in Rabbit Arteries."
Transfusion Medicine - "Activated Protein C-Mediated Inactivation of Recombinant Human Factor Va."
Transplantation Medicine - "Human VEGF Gene Transfer into Vascular Prosthesis."
Antisense Technology - "Relative Levels of Inhibition of p24 Gene Expression by Different 20-mer Antisense Oligonucleotide Sequences Targeting Nucleotides +1129 to +1268 of the HIV-1 Gag Genome: An Analysis of Mechanism."
Somatic Gene Therapy - "Human Somatic Cell Gene Therapy."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.